News
Everyone has heard of menopause but what about its long-neglected male cousin, andropause? Men also experience hormonal ...
Osteoporosis screening rates were below 20% among male patients 70 years of age and older and those with high-risk factors ...
In both children and adults, the drug allows for decreasing glucocorticoid dosing to physiological levels while still ...
Mereo BioPharma Group plc’s MREO share price has dipped by 5.63%, which has investors questioning if this is right time to ...
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that it will present ...
Treating lupus nephritis to achieve sustained remission for at least 3 years likely protects kidney function. In patients with active lupus nephritis, at least 3 years of sustained clinical ...
Lupus nephritis frequently recurs in the transplanted kidney, sometimes without clinical signs. Lupus nephritis frequently recurs after kidney transplantation, and it may be clinically quiescent ...
I am a 69-year-old woman. I’m in good health despite various events that happened last year (i.e., a hole in my stomach ...
So it was both her love for her daughter and desire to do better for herself that sparked the creation of her new passion project: Reframe, a clinical skin care line that officially launches on ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...
Some of these drugs, such as thiol agents, also have antioxidative effects that may contribute to their clinical effects.
Yet, some use cases can be more easily applied to almost every clinical trial organisation. This article outlines some practical GenAI use cases in clinical trials and discusses the most popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results